BioShares Biotechnology Clinical Trials ETF Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
BioShares Biotechnology Clinical Trials ETF upgraded from Sell Candidate to Hold/Accumulate after Thursday trading session.
(Updated on Apr 18, 2024)
The BioShares Biotechnology Clinical Trials ETF price fell by -1.32% on the last day (Thursday, 18th Apr 2024) from $25.82 to $25.48. It has now fallen 5 days in a row. During the last trading day the ETF fluctuated 0.413% from a day low at $25.38 to a day high of $25.48. The price has fallen in 6 of the last 10 days and is down by -5.77% for this period. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -1 thousand shares and in total, 233 shares were bought and sold for approximately $5.94 thousand.
Given the current short-term trend, the ETF is expected to rise 7.00% during the next 3 months and, with a 90% probability hold a price between $27.26 and $34.76 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BBC Signals & Forecast
There are few to no technical positive signals at the moment. The BioShares Biotechnology Clinical Trials ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $26.65 and $28.59. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -18.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this ETF may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. The ETF had a Golden Star Signal on Thursday, June 01, 2023 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Golden Star 12 Months
The ETF had a Golden Star Signal on Thursday, June 01, 2023 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Support, Risk & Stop-loss for BioShares Biotechnology Clinical Trials ETF
BioShares Biotechnology Clinical Trials finds support from accumulated volume at $24.97 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.105 between high and low, or 0.413%. For the last week the ETF has had daily average volatility of 1.05%.
Our recommended stop-loss: $23.81 (-6.56%) (This ETF has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 33 days ago.)
Trading Expectations (BBC) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect BioShares Biotechnology Clinical Trials Fund to open at $25.45, and during the day (based on 14 day Average True Range), to move between $24.87 and $26.09, which gives a possible trading interval of +/-$0.614 (+/-2.41%) up or down from last closing price. If BioShares Biotechnology Clinical Trials Fund takes out the full calculated possible swing range there will be an estimated 4.82% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $24.97 (2.02%) than the resistance at $26.58 (4.32%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is BioShares Biotechnology Clinical Trials Fund ETF A Buy?
BioShares Biotechnology Clinical Trials holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: -0.817 Hold/Accumulate Upgraded
Predicted Opening Price for BioShares Biotechnology Clinical Trials Fund of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $25.45 ( 0.137%) | $25.48 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BBC
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 25.55 | 0.274 % | |
| R2 | 25.51 | 0.117 % | ||
| R1 | 25.49 | 0.0200 % | ||
| Current price: | 25.48 | |||
| Support | S1 | 25.41 | -0.294 % | |
| S2 | 25.38 | -0.391 % | ||
| S3 | 25.34 | -0.548 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 30.94 | 21.43 % | |
| R2 | 27.67 | 8.60 % | ||
| R1 | 26.58 | 4.32 % | ||
| Current price | 25.48 | |||
| Support | S1 | 24.97 | -2.02% | |
| S2 | 24.63 | -3.34% | ||
| S3 | 23.85 | -6.40% |
BBC Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 20, 2023 | Dec 20, 2023 | Dec 20, 2023 | $0.0820 | 0.369% |
| 2 | Dec 19, 2017 | Dec 20, 2017 | Dec 27, 2017 | $0.297 | 1.04% |
| 3 | Dec 21, 2015 | Dec 21, 2015 | Dec 29, 2015 | $0.147 | 0.498% |
FAQ
Click here for our free guide on how to buy BioShares Biotechnology Clinical Trials Fund ETF.
